$PMC Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in PharMerica CORP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in PharMerica CORP. Get notifications about new insider transactions in PharMerica CORP for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 11 2017 | PMC | PharMerica CORP | WEISHAR GREGORY S | Chief Executive Off ... | Option Exercise | D | 10.84 | 182,801 | 1,981,563 | 0 | |
Dec 11 2017 | PMC | PharMerica CORP | WEISHAR GREGORY S | Chief Executive Off ... | Option Exercise | D | 0.00 | 146,521 | 0 | 0 | |
Dec 11 2017 | PMC | PharMerica CORP | WEISHAR GREGORY S | Chief Executive Off ... | Option Exercise | A | 0.00 | 146,521 | 0 | 146,521 | |
Dec 11 2017 | PMC | PharMerica CORP | WEISHAR GREGORY S | Chief Executive Off ... | Sell | S | 29.25 | 1,500 | 43,875 | 0 | 1.5 K to 0 (-100.00 %) |
Dec 11 2017 | PMC | PharMerica CORP | WEISHAR GREGORY S | Chief Executive Off ... | Sell | S | 29.25 | 519,589 | 15,197,978 | 0 | 519.6 K to 0 (-100.00 %) |
Dec 11 2017 | PMC | PharMerica CORP | WEISHAR GREGORY S | Chief Executive Off ... | Sell | D | 29.25 | 440,001 | 12,870,029 | 0 | 440 K to 0 (-100.00 %) |
Dec 11 2017 | PMC | PharMerica CORP | WEISHAR GREGORY S | Chief Executive Off ... | Gift | G | 0.00 | 51,282 | 0 | 444,001 | 495.3 K to 444 K (-10.35 %) |
Dec 08 2017 | PMC | PharMerica CORP | MEYERS GEOFFREY G | Director | Sell | D | 29.25 | 59,240 | 1,732,770 | 0 | 59.2 K to 0 (-100.00 %) |
Dec 08 2017 | PMC | PharMerica CORP | OAKLEY ROBERT A | Director | Sell | D | 29.25 | 57,275 | 1,675,294 | 0 | 57.3 K to 0 (-100.00 %) |
Dec 08 2017 | PMC | PharMerica CORP | LEPORE PATRICK G | Director | Sell | D | 29.25 | 29,570 | 864,923 | 0 | 29.6 K to 0 (-100.00 %) |
Dec 08 2017 | PMC | PharMerica CORP | DORR MARJORIE W | Director | Sell | D | 29.25 | 58,689 | 1,716,653 | 0 | 58.7 K to 0 (-100.00 %) |
Dec 08 2017 | PMC | PharMerica CORP | Dahl W Robert Jr | Director | Sell | D | 29.25 | 56,742 | 1,659,704 | 0 | 56.7 K to 0 (-100.00 %) |
Dec 08 2017 | PMC | PharMerica CORP | COLLINS FRANK E | Director | Sell | D | 29.25 | 60,262 | 1,762,664 | 0 | 60.3 K to 0 (-100.00 %) |
Dec 08 2017 | PMC | PharMerica CORP | COLLINS FRANK E | Director | Gift | G | 0.00 | 1,161 | 0 | 60,262 | 61.4 K to 60.3 K (-1.89 %) |
Dec 08 2017 | PMC | PharMerica CORP | Vishnubhatla Suresh | EVP, LTC Operations | Option Exercise | D | 10.84 | 20,719 | 224,594 | 0 | |
Dec 08 2017 | PMC | PharMerica CORP | Vishnubhatla Suresh | EVP, LTC Operations | Option Exercise | D | 0.00 | 41,758 | 0 | 0 | |
Dec 08 2017 | PMC | PharMerica CORP | Vishnubhatla Suresh | EVP, LTC Operations | Option Exercise | A | 0.00 | 41,758 | 0 | 41,758 | |
Dec 08 2017 | PMC | PharMerica CORP | Vishnubhatla Suresh | EVP, LTC Operations | Sell | D | 29.25 | 67,031 | 1,960,657 | 0 | 67 K to 0 (-100.00 %) |
Dec 08 2017 | PMC | PharMerica CORP | Tomassetti Berard | SVP and CAO | Option Exercise | D | 10.84 | 2,964 | 32,130 | 0 | |
Dec 08 2017 | PMC | PharMerica CORP | Tomassetti Berard | SVP and CAO | Option Exercise | D | 0.00 | 8,906 | 0 | 0 | |
Dec 08 2017 | PMC | PharMerica CORP | Tomassetti Berard | SVP and CAO | Option Exercise | A | 0.00 | 8,906 | 0 | 8,906 | |
Dec 08 2017 | PMC | PharMerica CORP | Tomassetti Berard | SVP and CAO | Sell | D | 29.25 | 14,599 | 427,021 | 0 | 14.6 K to 0 (-100.00 %) |
Dec 08 2017 | PMC | PharMerica CORP | McKay Robert A | SVP Purchasing,Trad ... | Sell | D | 29.25 | 89,314 | 2,612,435 | 0 | 89.3 K to 0 (-100.00 %) |
Dec 08 2017 | PMC | PharMerica CORP | Dries Robert E. | CFO | Option Exercise | D | 0.00 | 28,226 | 0 | 0 | |
Dec 08 2017 | PMC | PharMerica CORP | Dries Robert E. | CFO | Option Exercise | A | 0.00 | 28,226 | 0 | 28,226 | |
Dec 08 2017 | PMC | PharMerica CORP | Dries Robert E. | CFO | Sell | D | 29.25 | 28,226 | 825,611 | 0 | 28.2 K to 0 (-100.00 %) |
Dec 08 2017 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Option Exercise | D | 10.84 | 9,588 | 103,934 | 0 | |
Dec 08 2017 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Option Exercise | D | 0.00 | 29,672 | 0 | 0 | |
Dec 08 2017 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Option Exercise | A | 0.00 | 29,672 | 0 | 29,672 | |
Dec 08 2017 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Sell | D | 29.25 | 87,023 | 2,545,423 | 0 | 87 K to 0 (-100.00 %) |
Dec 08 2017 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Gift | G | 0.00 | 2,753 | 0 | 87,023 | 89.8 K to 87 K (-3.07 %) |
Nov 21 2017 | PMC | PharMerica CORP | McKay Robert A | SVP Purchasing,Trad ... | Payment of Exercise | F | 29.10 | 19,719 | 573,823 | 89,314 | 109 K to 89.3 K (-18.09 %) |
Nov 21 2017 | PMC | PharMerica CORP | McKay Robert A | SVP Purchasing,Trad ... | Grant | A | 0.00 | 22,730 | 0 | 109,033 | 86.3 K to 109 K (+26.34 %) |
Jun 16 2017 | PMC | PharMerica CORP | COLLINS FRANK E | Director | Grant | A | 0.00 | 4,817 | 0 | 61,423 | 56.6 K to 61.4 K (+8.51 %) |
Jun 16 2017 | PMC | PharMerica CORP | DORR MARJORIE W | Director | Grant | A | 0.00 | 4,817 | 0 | 58,689 | 53.9 K to 58.7 K (+8.94 %) |
Jun 16 2017 | PMC | PharMerica CORP | OAKLEY ROBERT A | Director | Grant | A | 0.00 | 4,817 | 0 | 57,275 | 52.5 K to 57.3 K (+9.18 %) |
Jun 16 2017 | PMC | PharMerica CORP | Dahl W Robert Jr | Director | Grant | A | 0.00 | 4,817 | 0 | 56,742 | 51.9 K to 56.7 K (+9.28 %) |
Jun 16 2017 | PMC | PharMerica CORP | LEPORE PATRICK G | Director | Grant | A | 0.00 | 4,817 | 0 | 29,570 | 24.8 K to 29.6 K (+19.46 %) |
Jun 16 2017 | PMC | PharMerica CORP | MEYERS GEOFFREY G | Director | Grant | A | 0.00 | 4,817 | 0 | 59,240 | 54.4 K to 59.2 K (+8.85 %) |
Apr 11 2017 | PMC | PharMerica CORP | WEISHAR GREGORY S | Chief Executive Off ... | Grant | A | 0.00 | 50,080 | 0 | 1,010,872 | 960.8 K to 1 M (+5.21 %) |
Apr 11 2017 | PMC | PharMerica CORP | Vishnubhatla Suresh | EVP, LTC Operations | Grant | A | 0.00 | 14,676 | 0 | 67,031 | 52.4 K to 67 K (+28.03 %) |
Apr 11 2017 | PMC | PharMerica CORP | Tomassetti Berard | SVP and CAO | Grant | A | 0.00 | 3,185 | 0 | 14,599 | 11.4 K to 14.6 K (+27.90 %) |
Apr 11 2017 | PMC | PharMerica CORP | McKay Robert A | SVP Purchasing,Trad ... | Grant | A | 0.00 | 7,659 | 0 | 86,303 | 78.6 K to 86.3 K (+9.74 %) |
Apr 11 2017 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Grant | A | 0.00 | 9,998 | 0 | 89,776 | 79.8 K to 89.8 K (+12.53 %) |
Mar 28 2017 | PMC | PharMerica CORP | Vishnubhatla Suresh | EVP, LTC Operations | Payment of Exercise | F | 23.60 | 2,391 | 56,428 | 52,355 | 54.7 K to 52.4 K (-4.37 %) |
Mar 28 2017 | PMC | PharMerica CORP | Vishnubhatla Suresh | EVP, LTC Operations | Grant | A | 0.00 | 4,673 | 0 | 54,746 | 50.1 K to 54.7 K (+9.33 %) |
Mar 28 2017 | PMC | PharMerica CORP | Tomassetti Berard | SVP and CAO | Payment of Exercise | F | 23.60 | 617 | 14,561 | 11,414 | 12 K to 11.4 K (-5.13 %) |
Mar 28 2017 | PMC | PharMerica CORP | Tomassetti Berard | SVP and CAO | Grant | A | 0.00 | 1,767 | 0 | 12,031 | 10.3 K to 12 K (+17.22 %) |
Mar 28 2017 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Payment of Exercise | F | 23.60 | 1,541 | 36,368 | 79,778 | 81.3 K to 79.8 K (-1.90 %) |
Mar 28 2017 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Grant | A | 0.00 | 4,253 | 0 | 81,319 | 77.1 K to 81.3 K (+5.52 %) |
Mar 28 2017 | PMC | PharMerica CORP | WEISHAR GREGORY S | Chief Executive Off ... | Payment of Exercise | F | 23.60 | 12,054 | 284,474 | 960,792 | 972.8 K to 960.8 K (-1.24 %) |
Mar 28 2017 | PMC | PharMerica CORP | WEISHAR GREGORY S | Chief Executive Off ... | Grant | A | 0.00 | 24,109 | 0 | 972,846 | 948.7 K to 972.8 K (+2.54 %) |
Mar 28 2017 | PMC | PharMerica CORP | McKay Robert A | SVP Purchasing,Trad ... | Payment of Exercise | F | 23.60 | 1,666 | 39,318 | 78,644 | 80.3 K to 78.6 K (-2.07 %) |
Mar 28 2017 | PMC | PharMerica CORP | McKay Robert A | SVP Purchasing,Trad ... | Grant | A | 0.00 | 3,257 | 0 | 80,310 | 77.1 K to 80.3 K (+4.23 %) |
Mar 21 2017 | PMC | PharMerica CORP | Tomassetti Berard | SVP and CAO | Payment of Exercise | F | 23.15 | 319 | 7,385 | 10,264 | 10.6 K to 10.3 K (-3.01 %) |
Mar 21 2017 | PMC | PharMerica CORP | Tomassetti Berard | SVP and CAO | Payment of Exercise | F | 22.50 | 461 | 10,373 | 10,583 | 11 K to 10.6 K (-4.17 %) |
Mar 21 2017 | PMC | PharMerica CORP | McKay Robert A | SVP Purchasing,Trad ... | Payment of Exercise | F | 23.15 | 1,057 | 24,470 | 77,053 | 78.1 K to 77.1 K (-1.35 %) |
Mar 21 2017 | PMC | PharMerica CORP | McKay Robert A | SVP Purchasing,Trad ... | Payment of Exercise | F | 22.50 | 1,496 | 33,660 | 78,110 | 79.6 K to 78.1 K (-1.88 %) |
Mar 21 2017 | PMC | PharMerica CORP | Vishnubhatla Suresh | EVP, LTC Operations | Payment of Exercise | F | 23.15 | 1,875 | 43,406 | 50,073 | 51.9 K to 50.1 K (-3.61 %) |
Mar 21 2017 | PMC | PharMerica CORP | Vishnubhatla Suresh | EVP, LTC Operations | Payment of Exercise | F | 22.50 | 2,729 | 61,403 | 51,948 | 54.7 K to 51.9 K (-4.99 %) |
Mar 21 2017 | PMC | PharMerica CORP | WEISHAR GREGORY S | Chief Executive Off ... | Payment of Exercise | F | 23.15 | 6,433 | 148,924 | 948,737 | 955.2 K to 948.7 K (-0.67 %) |
Mar 21 2017 | PMC | PharMerica CORP | WEISHAR GREGORY S | Chief Executive Off ... | Payment of Exercise | F | 22.50 | 9,640 | 216,900 | 955,170 | 964.8 K to 955.2 K (-1.00 %) |
Mar 21 2017 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Payment of Exercise | F | 23.15 | 982 | 22,733 | 77,066 | 78 K to 77.1 K (-1.26 %) |
Mar 21 2017 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Payment of Exercise | F | 22.50 | 1,374 | 30,915 | 78,048 | 79.4 K to 78 K (-1.73 %) |
Mar 17 2017 | PMC | PharMerica CORP | WEISHAR GREGORY S | Chief Executive Off ... | Option Exercise | M | 18.48 | 155,836 | 2,879,849 | 0 | |
Mar 17 2017 | PMC | PharMerica CORP | WEISHAR GREGORY S | Chief Executive Off ... | Buy | M | 18.48 | 155,836 | 2,879,849 | 964,810 | 809 K to 964.8 K (+19.26 %) |
Mar 15 2017 | PMC | PharMerica CORP | Vishnubhatla Suresh | EVP, LTC Operations | Payment of Exercise | F | 23.00 | 1,795 | 41,285 | 54,677 | 56.5 K to 54.7 K (-3.18 %) |
Mar 15 2017 | PMC | PharMerica CORP | McKay Robert A | SVP Purchasing,Trad ... | Payment of Exercise | F | 23.00 | 1,292 | 29,716 | 79,606 | 80.9 K to 79.6 K (-1.60 %) |
Mar 15 2017 | PMC | PharMerica CORP | Tomassetti Berard | SVP and CAO | Payment of Exercise | F | 23.00 | 358 | 8,234 | 11,044 | 11.4 K to 11 K (-3.14 %) |
Mar 15 2017 | PMC | PharMerica CORP | WEISHAR GREGORY S | Chief Executive Off ... | Payment of Exercise | F | 23.00 | 5,987 | 137,701 | 808,974 | 815 K to 809 K (-0.73 %) |
Mar 15 2017 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Payment of Exercise | F | 23.00 | 1,239 | 28,497 | 79,422 | 80.7 K to 79.4 K (-1.54 %) |
Feb 01 2017 | PMC | PharMerica CORP | Dries Robert E. | CFO | Grant | A | 0.00 | 28,226 | 0 | 28,226 | 0 to 28.2 K |
Nov 03 2016 | PMC | PharMerica CORP | MEYERS GEOFFREY G | Director | Option Exercise | M | 15.06 | 29,268 | 440,776 | 0 | |
Nov 03 2016 | PMC | PharMerica CORP | MEYERS GEOFFREY G | Director | Payment of Exercise | F | 23.80 | 18,520 | 440,776 | 54,423 | 72.9 K to 54.4 K (-25.39 %) |
Nov 03 2016 | PMC | PharMerica CORP | MEYERS GEOFFREY G | Director | Buy | M | 15.06 | 29,268 | 440,776 | 72,943 | 43.7 K to 72.9 K (+67.01 %) |
Aug 02 2016 | PMC | PharMerica CORP | FROESEL DAVID W JR | Executive VP, CFO & ... | Payment of Exercise | F | 26.42 | 9,892 | 261,347 | 82,371 | 92.3 K to 82.4 K (-10.72 %) |
Jun 21 2016 | PMC | PharMerica CORP | COLLINS FRANK E | Director | Grant | A | 0.00 | 5,167 | 0 | 56,606 | 51.4 K to 56.6 K (+10.04 %) |
Jun 21 2016 | PMC | PharMerica CORP | DORR MARJORIE W | Director | Grant | A | 0.00 | 5,167 | 0 | 53,872 | 48.7 K to 53.9 K (+10.61 %) |
Jun 21 2016 | PMC | PharMerica CORP | GERRITY THOMAS P | Director | Grant | A | 0.00 | 5,167 | 0 | 53,312 | 48.1 K to 53.3 K (+10.73 %) |
Jun 21 2016 | PMC | PharMerica CORP | LEPORE PATRICK G | Director | Grant | A | 0.00 | 5,167 | 0 | 24,753 | 19.6 K to 24.8 K (+26.38 %) |
Jun 21 2016 | PMC | PharMerica CORP | MEYERS GEOFFREY G | Director | Grant | A | 0.00 | 5,167 | 0 | 43,675 | 38.5 K to 43.7 K (+13.42 %) |
Jun 21 2016 | PMC | PharMerica CORP | OAKLEY ROBERT A | Director | Grant | A | 0.00 | 5,167 | 0 | 52,458 | 47.3 K to 52.5 K (+10.93 %) |
Jun 21 2016 | PMC | PharMerica CORP | Dahl W Robert Jr | Director | Grant | A | 0.00 | 5,167 | 0 | 51,925 | 46.8 K to 51.9 K (+11.05 %) |
Jun 21 2016 | PMC | PharMerica CORP | MAC MAHON THOMAS P | Director | Grant | A | 0.00 | 5,167 | 0 | 58,606 | 53.4 K to 58.6 K (+9.67 %) |
Mar 23 2016 | PMC | PharMerica CORP | Tomassetti Berard | SVP and CAO | Payment of Exercise | F | 20.45 | 278 | 5,685 | 11,402 | 11.7 K to 11.4 K (-2.38 %) |
Mar 23 2016 | PMC | PharMerica CORP | McKay Robert A | SVP Purchasing,Trad ... | Payment of Exercise | F | 20.45 | 1,062 | 21,718 | 80,898 | 82 K to 80.9 K (-1.30 %) |
Mar 23 2016 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Payment of Exercise | F | 20.45 | 1,386 | 28,344 | 80,661 | 82 K to 80.7 K (-1.69 %) |
Mar 23 2016 | PMC | PharMerica CORP | FROESEL DAVID W JR | Executive VP, CFO & ... | Payment of Exercise | F | 20.45 | 2,570 | 52,557 | 92,263 | 94.8 K to 92.3 K (-2.71 %) |
Mar 23 2016 | PMC | PharMerica CORP | Vishnubhatla Suresh | EVP, LTC Operations | Payment of Exercise | F | 20.45 | 1,707 | 34,908 | 56,472 | 58.2 K to 56.5 K (-2.93 %) |
Mar 23 2016 | PMC | PharMerica CORP | Lindemoen Mark | SVP Sales and Clien ... | Payment of Exercise | F | 20.45 | 887 | 18,139 | 25,036 | 25.9 K to 25 K (-3.42 %) |
Mar 21 2016 | PMC | PharMerica CORP | WEISHAR GREGORY S | Chief Executive Off ... | Grant | A | 0.00 | 57,841 | 0 | 814,961 | 757.1 K to 815 K (+7.64 %) |
Mar 21 2016 | PMC | PharMerica CORP | WEISHAR GREGORY S | Chief Executive Off ... | Grant | A | 0.00 | 64,528 | 0 | 757,120 | 692.6 K to 757.1 K (+9.32 %) |
Mar 21 2016 | PMC | PharMerica CORP | Vishnubhatla Suresh | EVP, LTC Operations | Grant | A | 0.00 | 16,086 | 0 | 58,179 | 42.1 K to 58.2 K (+38.22 %) |
Mar 21 2016 | PMC | PharMerica CORP | Vishnubhatla Suresh | EVP, LTC Operations | Payment of Exercise | F | 19.99 | 3,664 | 73,243 | 42,093 | 45.8 K to 42.1 K (-8.01 %) |
Mar 21 2016 | PMC | PharMerica CORP | Vishnubhatla Suresh | EVP, LTC Operations | Grant | A | 0.00 | 7,870 | 0 | 45,757 | 37.9 K to 45.8 K (+20.77 %) |
Mar 21 2016 | PMC | PharMerica CORP | Tomassetti Berard | SVP and CAO | Grant | A | 0.00 | 3,358 | 0 | 11,680 | 8.3 K to 11.7 K (+40.35 %) |
Mar 21 2016 | PMC | PharMerica CORP | Tomassetti Berard | SVP and CAO | Payment of Exercise | F | 19.99 | 1,564 | 31,264 | 8,322 | 9.9 K to 8.3 K (-15.82 %) |
Mar 21 2016 | PMC | PharMerica CORP | Tomassetti Berard | SVP and CAO | Grant | A | 0.00 | 4,337 | 0 | 9,886 | 5.5 K to 9.9 K (+78.16 %) |
Mar 21 2016 | PMC | PharMerica CORP | McKay Robert A | SVP Purchasing,Trad ... | Grant | A | 0.00 | 8,846 | 0 | 81,960 | 73.1 K to 82 K (+12.10 %) |
Mar 21 2016 | PMC | PharMerica CORP | McKay Robert A | SVP Purchasing,Trad ... | Payment of Exercise | F | 19.99 | 5,793 | 115,802 | 73,114 | 78.9 K to 73.1 K (-7.34 %) |
Mar 21 2016 | PMC | PharMerica CORP | McKay Robert A | SVP Purchasing,Trad ... | Grant | A | 0.00 | 11,325 | 0 | 78,907 | 67.6 K to 78.9 K (+16.76 %) |
Mar 21 2016 | PMC | PharMerica CORP | Lindemoen Mark | SVP Sales and Clien ... | Grant | A | 0.00 | 6,253 | 0 | 25,923 | 19.7 K to 25.9 K (+31.79 %) |
Mar 21 2016 | PMC | PharMerica CORP | Lindemoen Mark | SVP Sales and Clien ... | Payment of Exercise | F | 19.99 | 3,516 | 70,285 | 19,670 | 23.2 K to 19.7 K (-15.16 %) |
Mar 21 2016 | PMC | PharMerica CORP | Lindemoen Mark | SVP Sales and Clien ... | Grant | A | 0.00 | 7,029 | 0 | 23,186 | 16.2 K to 23.2 K (+43.50 %) |
Mar 21 2016 | PMC | PharMerica CORP | FROESEL DAVID W JR | Executive VP, CFO & ... | Grant | A | 0.00 | 22,324 | 0 | 94,833 | 72.5 K to 94.8 K (+30.79 %) |
Mar 21 2016 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Grant | A | 0.00 | 11,548 | 0 | 82,047 | 70.5 K to 82 K (+16.38 %) |
Mar 21 2016 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Payment of Exercise | F | 19.99 | 7,631 | 152,544 | 70,499 | 78.1 K to 70.5 K (-9.77 %) |
Mar 21 2016 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Grant | A | 0.00 | 14,918 | 0 | 78,130 | 63.2 K to 78.1 K (+23.60 %) |
Mar 15 2016 | PMC | PharMerica CORP | Lindemoen Mark | SVP Sales and Clien ... | Payment of Exercise | F | 21.65 | 537 | 11,626 | 16,157 | 16.7 K to 16.2 K (-3.22 %) |
Mar 15 2016 | PMC | PharMerica CORP | McKay Robert A | SVP Purchasing,Trad ... | Payment of Exercise | F | 21.65 | 1,150 | 24,898 | 67,582 | 68.7 K to 67.6 K (-1.67 %) |
Mar 15 2016 | PMC | PharMerica CORP | Vishnubhatla Suresh | EVP, LTC Operations | Payment of Exercise | F | 21.65 | 1,499 | 32,453 | 37,887 | 39.4 K to 37.9 K (-3.81 %) |
Mar 15 2016 | PMC | PharMerica CORP | FROESEL DAVID W JR | Executive VP, CFO & ... | Payment of Exercise | F | 21.65 | 2,893 | 62,633 | 72,509 | 75.4 K to 72.5 K (-3.84 %) |
Mar 15 2016 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Payment of Exercise | F | 21.65 | 1,520 | 32,908 | 63,212 | 64.7 K to 63.2 K (-2.35 %) |
Mar 15 2016 | PMC | PharMerica CORP | Tomassetti Berard | SVP and CAO | Payment of Exercise | F | 21.65 | 357 | 7,729 | 5,549 | 5.9 K to 5.5 K (-6.04 %) |
Mar 09 2016 | PMC | PharMerica CORP | Vishnubhatla Suresh | EVP, LTC Operations | Payment of Exercise | F | 23.48 | 1,075 | 25,241 | 39,386 | 40.5 K to 39.4 K (-2.66 %) |
Mar 09 2016 | PMC | PharMerica CORP | WEISHAR GREGORY S | Chief Executive Off ... | Payment of Exercise | F | 23.48 | 11,152 | 261,849 | 692,592 | 703.7 K to 692.6 K (-1.58 %) |
Mar 09 2016 | PMC | PharMerica CORP | Lindemoen Mark | SVP Sales and Clien ... | Payment of Exercise | F | 23.48 | 1,315 | 30,876 | 16,694 | 18 K to 16.7 K (-7.30 %) |
Mar 09 2016 | PMC | PharMerica CORP | McKay Robert A | SVP Purchasing,Trad ... | Payment of Exercise | F | 23.48 | 2,074 | 48,698 | 68,732 | 70.8 K to 68.7 K (-2.93 %) |
Mar 09 2016 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Payment of Exercise | F | 23.48 | 2,667 | 62,621 | 64,732 | 67.4 K to 64.7 K (-3.96 %) |
Mar 09 2016 | PMC | PharMerica CORP | Tomassetti Berard | SVP and CAO | Payment of Exercise | F | 23.48 | 599 | 14,065 | 5,906 | 6.5 K to 5.9 K (-9.21 %) |
Feb 12 2016 | PMC | PharMerica CORP | WEISHAR GREGORY S | Chief Executive Off ... | Option Exercise | M | 14.89 | 166,664 | 2,481,627 | 0 | |
Feb 12 2016 | PMC | PharMerica CORP | WEISHAR GREGORY S | Chief Executive Off ... | Payment of Exercise | F | 27.75 | 123,090 | 3,415,748 | 703,744 | 826.8 K to 703.7 K (-14.89 %) |
Feb 12 2016 | PMC | PharMerica CORP | WEISHAR GREGORY S | Chief Executive Off ... | Buy | M | 14.89 | 166,664 | 2,481,627 | 826,834 | 660.2 K to 826.8 K (+25.25 %) |
Jan 19 2016 | PMC | PharMerica CORP | DORR MARJORIE W | Director | Option Exercise | M | 15.89 | 13,831 | 219,775 | 0 | |
Jan 19 2016 | PMC | PharMerica CORP | DORR MARJORIE W | Director | Payment of Exercise | F | 31.48 | 6,981 | 219,762 | 48,705 | 55.7 K to 48.7 K (-12.54 %) |
Jan 19 2016 | PMC | PharMerica CORP | DORR MARJORIE W | Director | Buy | M | 15.89 | 13,831 | 219,775 | 55,686 | 41.9 K to 55.7 K (+33.05 %) |
Dec 03 2015 | PMC | PharMerica CORP | McKay Robert A | SVP Purchasing,Trad ... | Sell | S | 34.42 | 2,993 | 103,012 | 70,806 | 73.8 K to 70.8 K (-4.06 %) |
Nov 16 2015 | PMC | PharMerica CORP | McKay Robert A | SVP Purchasing,Trad ... | Option Exercise | M | 10.84 | 8,183 | 88,704 | 0 | |
Nov 16 2015 | PMC | PharMerica CORP | McKay Robert A | SVP Purchasing,Trad ... | Payment of Exercise | F | 34.35 | 5,190 | 178,277 | 73,799 | 79 K to 73.8 K (-6.57 %) |
Nov 16 2015 | PMC | PharMerica CORP | McKay Robert A | SVP Purchasing,Trad ... | Buy | M | 10.84 | 8,183 | 88,704 | 78,989 | 70.8 K to 79 K (+11.56 %) |
Nov 12 2015 | PMC | PharMerica CORP | Lindemoen Mark | SVP Sales and Clien ... | Sell | S | 34.71 | 3,790 | 131,540 | 18,009 | 21.8 K to 18 K (-17.39 %) |
Sep 30 2015 | PMC | PharMerica CORP | Lindemoen Mark | SVP Sales and Clien ... | Payment of Exercise | F | 28.49 | 3,558 | 101,367 | 21,799 | 25.4 K to 21.8 K (-14.03 %) |
Aug 05 2015 | PMC | PharMerica CORP | FROESEL DAVID W JR | Executive VP, CFO & ... | Payment of Exercise | F | 33.90 | 8,182 | 277,370 | 75,402 | 83.6 K to 75.4 K (-9.79 %) |
Jul 17 2015 | PMC | PharMerica CORP | Dahl W Robert Jr | Director | Option Exercise | M | 22.97 | 9,568 | 219,777 | 0 | |
Jul 17 2015 | PMC | PharMerica CORP | Dahl W Robert Jr | Director | Payment of Exercise | F | 36.33 | 6,050 | 219,797 | 46,758 | 52.8 K to 46.8 K (-11.46 %) |
Jul 17 2015 | PMC | PharMerica CORP | Dahl W Robert Jr | Director | Buy | M | 22.97 | 9,568 | 219,777 | 52,808 | 43.2 K to 52.8 K (+22.13 %) |
Jun 23 2015 | PMC | PharMerica CORP | OAKLEY ROBERT A | Director | Grant | A | 0.00 | 3,730 | 0 | 47,291 | 43.6 K to 47.3 K (+8.56 %) |
Jun 23 2015 | PMC | PharMerica CORP | GERRITY THOMAS P | Director | Grant | A | 0.00 | 3,730 | 0 | 48,145 | 44.4 K to 48.1 K (+8.40 %) |
Jun 23 2015 | PMC | PharMerica CORP | DORR MARJORIE W | Director | Grant | A | 0.00 | 3,730 | 0 | 41,855 | 38.1 K to 41.9 K (+9.78 %) |
Jun 23 2015 | PMC | PharMerica CORP | Dahl W Robert Jr | Director | Grant | A | 0.00 | 3,730 | 0 | 43,240 | 39.5 K to 43.2 K (+9.44 %) |
Jun 23 2015 | PMC | PharMerica CORP | COLLINS FRANK E | Director | Grant | A | 0.00 | 3,730 | 0 | 51,439 | 47.7 K to 51.4 K (+7.82 %) |
Jun 23 2015 | PMC | PharMerica CORP | MAC MAHON THOMAS P | Director | Grant | A | 0.00 | 3,730 | 0 | 53,439 | 49.7 K to 53.4 K (+7.50 %) |
Jun 23 2015 | PMC | PharMerica CORP | MEYERS GEOFFREY G | Director | Grant | A | 0.00 | 3,730 | 0 | 38,508 | 34.8 K to 38.5 K (+10.73 %) |
Jun 23 2015 | PMC | PharMerica CORP | LEPORE PATRICK G | Director | Grant | A | 0.00 | 3,730 | 0 | 19,586 | 15.9 K to 19.6 K (+23.52 %) |
Jun 17 2015 | PMC | PharMerica CORP | McKay Robert A | SVP Purchasing,Trad ... | Sell | S | 32.75 | 7,000 | 229,268 | 70,806 | 77.8 K to 70.8 K (-9.00 %) |
Jun 04 2015 | PMC | PharMerica CORP | WEISHAR GREGORY S | Chief Executive Off ... | Sell | S | 32.62 | 7,000 | 228,346 | 0 | 7 K to 0 (-100.00 %) |
Jun 04 2015 | PMC | PharMerica CORP | WEISHAR GREGORY S | Chief Executive Off ... | Sell | S | 32.50 | 79,344 | 2,578,807 | 683,025 | 762.4 K to 683 K (-10.41 %) |
Jun 04 2015 | PMC | PharMerica CORP | WEISHAR GREGORY S | Chief Executive Off ... | Sell | S | 32.75 | 2,145 | 70,249 | 762,369 | 764.5 K to 762.4 K (-0.28 %) |
Jun 04 2015 | PMC | PharMerica CORP | WEISHAR GREGORY S | Chief Executive Off ... | Sell | S | 33.29 | 15,661 | 521,403 | 764,514 | 780.2 K to 764.5 K (-2.01 %) |
Jun 03 2015 | PMC | PharMerica CORP | Lindemoen Mark | SVP Sales and Clien ... | Sell | S | 33.27 | 4,500 | 149,706 | 25,357 | 29.9 K to 25.4 K (-15.07 %) |